Facebook

Twitter

Tongue cancer can develop in either type of cell, but most cases occur in squamous cells. Tongue cancer is more common in men than women, and the average age at diagnosis is 60.
https://cancercelltreatment.com/2022/06/06/tongue-cancer-stages/

People with Lynch syndrome have a gene defect that helps repair DNA mistakes, which means that they are more likely to develop cancers.
https://cancercelltreatment.com/2022/07/03/types-of-lynch-syndrome-cancers/

Zinc stabilizes the molecular structure of cellular components and membranes and contributes in this way to the maintenance of cell and organ integrity.

In 1761, Giovanni Morgagni of Padua was the first to do something that is now routine; he did autopsies to relate the patient's illness to pathological findings after death.
https://cancercelltreatment.com/2022/04/18/cancer-facts/

Removing these dead cells can improve the body's response to treatment, prevent recurrence, and enhance the quality of life for patients.
https://cancercelltreatment.com/2024/03/21/clear-dead-cancer-cells/

Load More

Current and Future Clinical Cancer Advances

February 9, 2021
Est. Reading: 1 minute

Clinical cancer advances in research are featured in this year’s 2021 ASCO report reflecting progress in various cancers and across prevention and treatment.

Highlights in the Report Cancer Advances:

  • Molecular Profiling Drives Progress in GI Cancers.
  • Antibody-Drug Conjugate Shows Promise in GI Cancers.
  • Pembrolizumab Doubles Time to Disease Progression in Patients With Advanced Colorectal Cancer With DNA Mismatch Repair Deficiency.
  • Progress in bringing targeted therapies to patients with earlier-stage disease.
  • Biomarker-driven treatment approaches offer more personalized care for lung, colorectal, and gastric cancers.
  • Combinations of different therapies extend survival without increasing toxicity.
  • A growing number of targeted therapies offer extended survival for more patients with difficult-to-treat cancers.

Current and Future Clinical Cancer Advances

Research Priorities in Clinical Cancer for 2021

  • Develop and Integrate Artificial Intelligence and Deep Learning in Cancer Research
  • Identify Strategies That Predict Response and Resistance to Immunotherapies
  • Optimize Multimodality Treatment for Solid Tumors
  • Increase Precision Medicine Research and Treatment Approaches in Pediatric and Other Rare Cancers
  • Optimize Care for Older Adults With Cancer
  • Increase Equitable Access to Cancer Clinical Trials
  • Reduce Adverse Consequences of Cancer Treatment
  • Reduce Obesity’s Impact on Cancer Incidence and Outcomes
  • Better Identify Potentially Malignant Lesions and Predict When Treatment is Needed

Problems in Clinical Cancer 2021

The COVID-19 public health emergency threatens to reverse years of momentum in cancer research. Laboratories conducting cancer research have closed, or space has been redirected to COVID-19 research. Clinical trials and cancer advances have halted or slowed, creating a costly loss in research progress and delays in patient access to potentially life-saving treatments.

For more information on promising cancer cell treatments, visit: https://cancer-cell-treatment.com

Sharing is caring

Leave a Reply

Copyright © 2024 All Rights Reserved
cross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram